United Arab Emirates

Celularity and CH Trading Group Announce Product Distribution Agreement with Tamer Group to be the Exclusive Distributor for the Kingdom of Saudi Arabia

Retrieved on: 
Wednesday, January 11, 2023

Celularity Inc. (Nasdaq: CELU) (“Celularity”), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC (“CH Trading Group”), an international import, export and trading company, today announced that they have entered into an exclusive distribution agreement with the Tamer Group (“Tamer”).

Key Points: 
  • Celularity Inc. (Nasdaq: CELU) (“Celularity”), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC (“CH Trading Group”), an international import, export and trading company, today announced that they have entered into an exclusive distribution agreement with the Tamer Group (“Tamer”).
  • The Tamer Group, a leading Middle East healthcare distribution company, will be the exclusive distributor for Celularity’s branded regenerative biomaterial products in Saudi Arabia.
  • “We are looking forward to partnering with Celularity and CH Group on this exciting opportunity across Saudi Arabia and providing unprecedented access to these cutting-edge therapeutics to all members of the community,” stated Dr. Yasser Khattab, Tamer Group Healthcare CEO.
  • “Saudi Arabia is a prime market for Celularity’s commercial regenerative biomaterial products,” said CEO of CH Trading Group, Sayed Zayan.

Celularity and CH Trading Group Announce Territory Distribution Agreement for the Middle East

Retrieved on: 
Wednesday, January 11, 2023

Celularity Inc. (Nasdaq: CELU) (“Celularity”), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC (“CH Trading Group”), an international import, export and trading company, today announced that they have entered into an exclusive territory distribution agreement.

Key Points: 
  • Celularity Inc. (Nasdaq: CELU) (“Celularity”), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC (“CH Trading Group”), an international import, export and trading company, today announced that they have entered into an exclusive territory distribution agreement.
  • CH Trading Group will act as the exclusive territories distributor of Celularity’s previously announced Halal-Certified products within more than 100 countries.
  • The Product Distribution Agreement for Celularity’s Halal-Certified products provides for a five-year minimum aggregate purchase commitment of US $225 million dollars.
  • “Based on market demand for Celularity’s commercial biomaterial products, we believe there is a billion-dollar commercial opportunity across the Middle East North Africa Islamic markets,” said Sayed Zayan, CEO of CH Trading Group.

GCC Countries Shifting from Oil-driven Economies to Data-Driven Economies, More than $5.5 Billion Investment to be in GCC Data Center Market - Arizton

Retrieved on: 
Thursday, January 12, 2023

CHICAGO, Jan. 12, 2023 /PRNewswire/ -- According to Arizton's latest research report, the GCC data center market will witness investments of USD 5.50 billion by 2028. GCC is an emerging market in the Middle East. It promotes investments from foreign entities and provides support for investments with its macro-economic policies and other incentives for investors. In GCC region, the UAE, Saudi Arabia, Oman, Kuwait, and Bahrain are working toward achieving their renewable energy targets by 2030 and 2050.

Key Points: 
  • Check Out Some of the Top-Selling Market Research Reports:
    Saudi Arabia Data Center Market - The Saudi Arabia data center market is estimated to cross USD 1.77 billion by 2027.
  • United Arab Emirates Data Center Market - The United Arab Emirates data center market is expected to grow at a CAGR of 7.90% from 2022 to 2027 The United Arab Emirates is among the top data center markets in the Middle East.
  • Middle East and Africa Data Center Market - The Middle East and Africa data center market is expected to grow at a CAGR of over 10% from 2022 to 2027.
  • Middle East Data Center Market - The Middle east data center market will witness investments of USD 6.73 billion in 2027.

GCC Countries Shifting from Oil-driven Economies to Data-Driven Economies, More than $5.5 Billion Investment to be in GCC Data Center Market - Arizton

Retrieved on: 
Thursday, January 12, 2023

CHICAGO, Jan. 12, 2023 /PRNewswire/ -- According to Arizton's latest research report, the GCC data center market will witness investments of USD 5.50 billion by 2028. GCC is an emerging market in the Middle East. It promotes investments from foreign entities and provides support for investments with its macro-economic policies and other incentives for investors. In GCC region, the UAE, Saudi Arabia, Oman, Kuwait, and Bahrain are working toward achieving their renewable energy targets by 2030 and 2050.

Key Points: 
  • Check Out Some of the Top-Selling Market Research Reports:
    Saudi Arabia Data Center Market - The Saudi Arabia data center market is estimated to cross USD 1.77 billion by 2027.
  • United Arab Emirates Data Center Market - The United Arab Emirates data center market is expected to grow at a CAGR of 7.90% from 2022 to 2027 The United Arab Emirates is among the top data center markets in the Middle East.
  • Middle East and Africa Data Center Market - The Middle East and Africa data center market is expected to grow at a CAGR of over 10% from 2022 to 2027.
  • Middle East Data Center Market - The Middle east data center market will witness investments of USD 6.73 billion in 2027.

Celularity and CH Trading Group Announce Territory Distribution Agreement for the Middle East

Retrieved on: 
Wednesday, January 11, 2023

FLORHAM PARK, N.J., RIYADH, Saudi Arabia and JEDDAH, Saudi Arabia, Jan. 11, 2023 /PRNewswire/ -- Celularity Inc. (Nasdaq: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC ("CH Trading Group"), an international import, export and trading company, today announced that they have entered into an exclusive territory distribution agreement. CH Trading Group will act as the exclusive territories distributor of Celularity's previously announced Halal-Certified products within more than 100 countries. The Product Distribution Agreement for Celularity's Halal-Certified products provides for a five-year minimum aggregate purchase commitment of US $225 million dollars.   

Key Points: 
  • Relationship opens access to Celularity's Halal-Certified regenerative biomaterial, health and wellness products across the Middle East and the broader Islamic world
    FLORHAM PARK, N.J., RIYADH, Saudi Arabia and JEDDAH, Saudi Arabia, Jan. 11, 2023 /PRNewswire/ -- Celularity Inc. (Nasdaq: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC ("CH Trading Group"), an international import, export and trading company, today announced that they have entered into an exclusive territory distribution agreement.
  • CH Trading Group will act as the exclusive territories distributor of Celularity's previously announced Halal-Certified products within more than 100 countries.
  • The Product Distribution Agreement for Celularity's Halal-Certified products provides for a five-year minimum aggregate purchase commitment of US $225 million dollars.
  • "Based on market demand for Celularity's commercial biomaterial products, we believe there is a billion-dollar commercial opportunity across the Middle East North Africa Islamic markets," said Sayed Zayan,  CEO of CH Trading Group.

Celularity and CH Trading Group Announce Territory Distribution Agreement for the Middle East

Retrieved on: 
Wednesday, January 11, 2023

FLORHAM PARK, N.J., RIYADH, Saudi Arabia and JEDDAH, Saudi Arabia, Jan. 11, 2023 /PRNewswire/ -- Celularity Inc. (Nasdaq: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC ("CH Trading Group"), an international import, export and trading company, today announced that they have entered into an exclusive territory distribution agreement. CH Trading Group will act as the exclusive territories distributor of Celularity's previously announced Halal-Certified products within more than 100 countries. The Product Distribution Agreement for Celularity's Halal-Certified products provides for a five-year minimum aggregate purchase commitment of US $225 million dollars.   

Key Points: 
  • Relationship opens access to Celularity's Halal-Certified regenerative biomaterial, health and wellness products across the Middle East and the broader Islamic world
    FLORHAM PARK, N.J., RIYADH, Saudi Arabia and JEDDAH, Saudi Arabia, Jan. 11, 2023 /PRNewswire/ -- Celularity Inc. (Nasdaq: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC ("CH Trading Group"), an international import, export and trading company, today announced that they have entered into an exclusive territory distribution agreement.
  • CH Trading Group will act as the exclusive territories distributor of Celularity's previously announced Halal-Certified products within more than 100 countries.
  • The Product Distribution Agreement for Celularity's Halal-Certified products provides for a five-year minimum aggregate purchase commitment of US $225 million dollars.
  • "Based on market demand for Celularity's commercial biomaterial products, we believe there is a billion-dollar commercial opportunity across the Middle East North Africa Islamic markets," said Sayed Zayan,  CEO of CH Trading Group.

Celularity and CH Trading Group Announce Product Distribution Agreement with Tamer Group to be the Exclusive Distributor for the Kingdom of Saudi Arabia

Retrieved on: 
Wednesday, January 11, 2023

FLORHAM PARK, N.J, RIYADH, Saudi Arabia and JEDDAH, Saudi Arabia, Jan. 11, 2023 /PRNewswire/ -- Celularity Inc. (NASDAQ: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC ("CH Trading Group"), an international import, export and trading company, today announced that they have entered into an exclusive distribution agreement with the Tamer Group ("Tamer"). The Tamer Group, a leading Middle East healthcare distribution company, will be the exclusive distributor for Celularity's branded regenerative biomaterial products in Saudi Arabia.

Key Points: 
  • Tamer Group will be the exclusive distributor of the Celularity branded biomaterial products in Saudi Arabia, opening access to Celularity's Halal-Certified regenerative biomaterial, health and wellness products
    FLORHAM PARK, N.J, RIYADH, Saudi Arabia and JEDDAH, Saudi Arabia, Jan. 11, 2023 /PRNewswire/ -- Celularity Inc. (NASDAQ: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC ("CH Trading Group"), an international import, export and trading company, today announced that they have entered into an exclusive distribution agreement with the Tamer Group ("Tamer").
  • The Tamer Group, a leading Middle East healthcare distribution company, will be the exclusive distributor for Celularity's branded regenerative biomaterial products in Saudi Arabia.
  • "Saudi Arabia is a prime market for Celularity's commercial regenerative biomaterial products," said CEO of CH Trading Group, Sayed Zayan.
  • "We are excited to partner with Tamer Group and to be a part of fulfilling their commitment to the development of the Kingdom's healthcare sector."

Celularity and CH Trading Group Announce Product Distribution Agreement with Tamer Group to be the Exclusive Distributor for the Kingdom of Saudi Arabia

Retrieved on: 
Wednesday, January 11, 2023

FLORHAM PARK, N.J, RIYADH, Saudi Arabia and JEDDAH, Saudi Arabia , Jan. 11, 2023 /PRNewswire/ -- Celularity Inc. (NASDAQ: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC ("CH Trading Group"), an international import, export and trading company, today announced that they have entered into an exclusive distribution agreement with the Tamer Group ("Tamer"). The Tamer Group, a leading Middle East healthcare distribution company, will be the exclusive distributor for Celularity's branded regenerative biomaterial products in Saudi Arabia.

Key Points: 
  • Tamer Group will be the exclusive distributor of the Celularity branded biomaterial products in Saudi Arabia, opening access to Celularity's Halal-Certified regenerative biomaterial, health and wellness products
    FLORHAM PARK, N.J, RIYADH, Saudi Arabia and JEDDAH, Saudi Arabia , Jan. 11, 2023 /PRNewswire/ -- Celularity Inc. (NASDAQ: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC ("CH Trading Group"), an international import, export and trading company, today announced that they have entered into an exclusive distribution agreement with the Tamer Group ("Tamer").
  • The Tamer Group, a leading Middle East healthcare distribution company, will be the exclusive distributor for Celularity's branded regenerative biomaterial products in Saudi Arabia.
  • "Saudi Arabia is a prime market for Celularity's commercial regenerative biomaterial products," said CEO of CH Trading Group, Sayed Zayan.
  • "We are excited to partner with Tamer Group and to be a part of fulfilling their commitment to the development of the Kingdom's healthcare sector."

FREED GROUP announces addition of Connexus Travel, Hong Kong's first registered travel agent, to the FREED GROUP family

Retrieved on: 
Tuesday, January 31, 2023

HONG KONG, Jan 31, 2023 - (ACN Newswire) - FREED GROUP ("FREED"), an award-winning digital and smart merchandising solutions company, has announced that its Co-founder & CEO, Mr. Abel Zhao, has acquired Connexus Travel Limited ("Connexus Travel", formerly Swire Travel), a leading regional travel management company headquartered in Hong Kong.

Key Points: 
  • HONG KONG, Jan 31, 2023 - (ACN Newswire) - FREED GROUP ("FREED"), an award-winning digital and smart merchandising solutions company, has announced that its Co-founder & CEO, Mr. Abel Zhao, has acquired Connexus Travel Limited ("Connexus Travel", formerly Swire Travel), a leading regional travel management company headquartered in Hong Kong.
  • After the acquisition, Connexus will now become part of the FREED GROUP family.
  • Mr. Abel Zhao, Co-founder & CEO of FREED GROUP, said, "We are very pleased with having Connexus Travel in our FREED family, as Connexus Travel is a name trusted by corporate, leisure and MICE travellers.
  • Ultimately, we anticipate Connexus Travel to follow in the footsteps of FREED GROUP and transform into a global brand."

iSwiss Group Expands Services with Launch of iSwiss Insurance LLC - Plans to Expand to 27 Countries by 2023

Retrieved on: 
Tuesday, January 17, 2023

Lugano, Switzerland--(Newsfile Corp. - January 17, 2023) - iSwiss Insurance LLC , a subsidiary of the iSwiss group, has officially launched with a capital of $100 million.

Key Points: 
  • Lugano, Switzerland--(Newsfile Corp. - January 17, 2023) - iSwiss Insurance LLC , a subsidiary of the iSwiss group, has officially launched with a capital of $100 million.
  • The company aims to provide insurance services in addition to payment and credit services to those excluded from the traditional banking system, also known as the underbanking population.
  • The company currently providses insurance services in a few countries, such as the United Arab Emirates, but plans to expand to 27 different countries by 2023.
  • iSwiss Insurance LLC is also set to launch its Insurtech platform, where companies and individuals will be able to purchase policies independently and intuitively, paying directly on the platform.